Sherlock Biosciences is disrupting diagnostics
Sherlock Biosciences was founded on the belief that we can vastly improve human health and industrial testing worldwide.
Diagnostic tests developed with our Engineering Biology platforms will help us deliver results faster, accurately and more affordably.
We envision a world where Sherlock’s products will enable users to make more effective decisions in any environment, including hospitals, industrial settings, low-resource settings, or at home.
Our goal is to address significant unmet needs in infectious disease, oncology, agriculture, and other areas to transform diagnostic testing and global public health.
We are committed to making a positive impact on human health, including in low-resource settings, where rapid diagnostic testing has the potential to transform lives through better health care and safer food and water.Meet our team
Broad partnerships accelerate the pace of improved health
We are partnering with pharmaceutical companies, diagnostic companies, and medical device companies as well as Global Health institutions, to develop diagnostic solutions powered by our proprietary CRISPR and Synthetic Biology platform for DNA and RNA detection.
Our versatile platform enables the development of decentralized diagnostic products that can operate at ambient temperature without complex instrumentation in simple-to-use formats, opening a wide range of potential applications in areas including infectious disease, early detection of cancer, treatment monitoring, and precision medicine.